Optic neuritis associated with adalimumab in the treatment of uveitis.
about
Gender disparities in ocular inflammatory disordersToxic optic neuropathies: an updated reviewTumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis.Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients.Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.Safety of biologic therapy in rheumatoid arthritis.Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature.Orbital and optic nerve complications of inflammatory bowel disease.A systematic review of biologics for the treatment of noninfectious uveitis.TNF inhibition for ophthalmic indications: current status and outlook.The Use of Biologic Therapies in Uveitis.Research Registries: A Tool to Advance Understanding of Rare Neuro-Ophthalmic Diseases.Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.Bilateral optic neuritis associated with the use of infliximabAdalimumab and Non-Arteritic Anterior Ischaemic Optic Neuropathy: A Case ReportUnilateral and irreversible optic neuropathy associated to infliximab treatment: 3-year follow-up.Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases.
P2860
Q26995402-2CBBE2A0-29C7-498A-A310-359BF45FDF71Q27025010-663A2CD9-0B21-4AB8-8B84-A6BA7052EB98Q36574105-6693FB41-2360-47A6-9AA4-D36AFBFC8DCEQ36894072-43350239-4EAF-4684-AF35-519410D32F17Q37118403-AD4B7515-DCB4-45BA-B37D-522B89326EE7Q37911726-20C47419-75B7-4DDE-A942-8B0B7866C89DQ37944433-556590C1-6328-45AC-ACD4-E7EF0A286D2CQ37977994-D23ABE3C-FD5A-4540-A4D9-636727F65477Q38053517-2098ED0A-6217-42BE-8326-BB23426F1FA9Q38068969-D88E3097-D098-44C5-9DD2-7B3F48B64B30Q38097327-8A434C73-E5B3-4ACF-BE70-9B6119CE5D2AQ38272248-087934C9-C110-476B-9E27-B68FD1A768F5Q38844159-82C5868C-C244-44A8-B86D-821F63B507EFQ40166499-8E8FFE61-EAC4-4B5C-A2C5-0EEF26EE819DQ41904838-715F05C8-3962-4AAB-B6F2-EE872C609A06Q42363512-5BE6ACDE-FAF7-4581-8FDE-B7D0F083160DQ47608255-84D1F580-EE47-4929-8140-EA790A94470CQ52541392-237EF636-B588-4A36-B34D-9066D9BA03E9Q54645310-72780C01-E62D-43CB-91E8-77413959E4A1
P2860
Optic neuritis associated with adalimumab in the treatment of uveitis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Optic neuritis associated with adalimumab in the treatment of uveitis.
@ast
Optic neuritis associated with adalimumab in the treatment of uveitis.
@en
type
label
Optic neuritis associated with adalimumab in the treatment of uveitis.
@ast
Optic neuritis associated with adalimumab in the treatment of uveitis.
@en
prefLabel
Optic neuritis associated with adalimumab in the treatment of uveitis.
@ast
Optic neuritis associated with adalimumab in the treatment of uveitis.
@en
P2093
P2860
P1476
Optic neuritis associated with adalimumab in the treatment of uveitis.
@en
P2093
Andrea D Birnbaum
Debra A Goldstein
Sing Your Li
P2860
P304
P356
10.3109/09273948.2010.495814
P577
2010-09-01T00:00:00Z